| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 27/12/2024 | 23:15 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:PRPH | ProPhase Labs Inc |
| 11/12/2024 | 14:00 | GlobeNewswire Inc. | ProPhase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Adds Seasoned Industry Expert, and Plans Significant Cost-Cutting Measures | NASDAQ:PRPH | ProPhase Labs Inc |
| 21/11/2024 | 06:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:PRPH | ProPhase Labs Inc |
| 19/11/2024 | 14:00 | GlobeNewswire Inc. | Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision | NASDAQ:PRPH | ProPhase Labs Inc |
| 13/11/2024 | 22:49 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:PRPH | ProPhase Labs Inc |
| 13/11/2024 | 14:00 | GlobeNewswire Inc. | ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2024 | NASDAQ:PRPH | ProPhase Labs Inc |
| 12/11/2024 | 23:30 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of 1933 | NASDAQ:PRPH | ProPhase Labs Inc |
| 12/11/2024 | 22:05 | GlobeNewswire Inc. | ProPhase Labs Announces Closing of Public Offering of Common Stock | NASDAQ:PRPH | ProPhase Labs Inc |
| 11/11/2024 | 15:52 | GlobeNewswire Inc. | ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024 | NASDAQ:PRPH | ProPhase Labs Inc |
| 08/11/2024 | 22:05 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] | NASDAQ:PRPH | ProPhase Labs Inc |
| 08/11/2024 | 05:37 | GlobeNewswire Inc. | ProPhase Labs Announces Pricing of Public Offering of Common Stock | NASDAQ:PRPH | ProPhase Labs Inc |
| 07/11/2024 | 22:05 | GlobeNewswire Inc. | ProPhase Labs Announces Proposed Public Offering of Common Stock | NASDAQ:PRPH | ProPhase Labs Inc |
| 04/11/2024 | 14:00 | GlobeNewswire Inc. | ProPhase Labs Launches DNA Complete®: Transforming Direct-to-Consumer Genetic Testing for Health, Wellness, and Enhanced Ancestry | NASDAQ:PRPH | ProPhase Labs Inc |
| 22/10/2024 | 14:00 | GlobeNewswire Inc. | ProPhase Labs to Present at the 2024 ThinkEquity Conference | NASDAQ:PRPH | ProPhase Labs Inc |
| 17/10/2024 | 14:00 | GlobeNewswire Inc. | ProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025 | NASDAQ:PRPH | ProPhase Labs Inc |
| 22/08/2024 | 12:07 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] | NASDAQ:PRPH | ProPhase Labs Inc |
| 19/08/2024 | 17:10 | GlobeNewswire Inc. | ProPhase Labs to Present at August 20th Virtual Investor Summit Microcap Event | NASDAQ:PRPH | ProPhase Labs Inc |
| 14/08/2024 | 14:00 | GlobeNewswire Inc. | ProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2024 | NASDAQ:PRPH | ProPhase Labs Inc |
| 13/08/2024 | 14:00 | GlobeNewswire Inc. | ProPhase Labs Announces Collaboration with Forward Healthcare Consultants to Aid in the Commercialization of its Billion Dollar Potential BE-Smart Esophageal Cancer Test | NASDAQ:PRPH | ProPhase Labs Inc |
| 09/08/2024 | 22:30 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB | NASDAQ:PRPH | ProPhase Labs Inc |
| 07/08/2024 | 14:00 | GlobeNewswire Inc. | PROPHASE LABS INC. TO PRESENT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 14 | NASDAQ:PRPH | ProPhase Labs Inc |
| 11/07/2024 | 14:00 | GlobeNewswire Inc. | ProPhase Labs Announces Update on Pharmaloz Manufacturing, Inc. Progress | NASDAQ:PRPH | ProPhase Labs Inc |
| 20/05/2024 | 22:20 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NASDAQ:PRPH | ProPhase Labs Inc |
| 09/05/2024 | 21:40 | GlobeNewswire Inc. | ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. - Updated | NASDAQ:PRPH | ProPhase Labs Inc |
| 09/05/2024 | 14:00 | GlobeNewswire Inc. | ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. | NASDAQ:PRPH | ProPhase Labs Inc |
| 02/05/2024 | 14:00 | GlobeNewswire Inc. | PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9 | NASDAQ:PRPH | ProPhase Labs Inc |
| 25/04/2024 | 14:00 | GlobeNewswire Inc. | ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024 | NASDAQ:PRPH | ProPhase Labs Inc |
| 16/04/2024 | 14:00 | GlobeNewswire Inc. | ProPhase Labs Unveils Project ZenQ-AI | NASDAQ:PRPH | ProPhase Labs Inc |
| 10/04/2024 | 14:00 | GlobeNewswire Inc. | ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024 | NASDAQ:PRPH | ProPhase Labs Inc |
| 02/04/2024 | 03:00 | GlobeNewswire Inc. | ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | NASDAQ:PRPH | ProPhase Labs Inc |